True Wealth Design’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$476K Sell
397
-36
-8% -$36.8K 0.11% 42
2026
Q1
$398K Buy
433
+259
+149% +$263K 0.11% 44
2025
Q4
$187K Buy
174
+23
+15% +$22K 0.05% 90
2025
Q3
$115K Buy
151
+2
+1% +$1.49K 0.04% 137
2025
Q2
$116K Buy
149
+10
+7% +$7.77K 0.04% 90
2025
Q1
$115K Buy
139
+8
+6% +$6.66K 0.04% 75
2024
Q4
$101K Buy
131
+15
+13% +$12.4K 0.04% 72
2024
Q3
$103K Sell
116
-34
-23% -$30.6K 0.04% 58
2024
Q2
$136K Buy
150
+6
+4% +$4.8K 0.03% 125
2024
Q1
$112K Buy
144
+107
+289% +$76.1K 0.03% 135
2023
Q4
$21.6K Hold
37
0.01% 198
2023
Q3
$19.9K Sell
37
-1
-3% -$515 0.01% 178
2023
Q2
$17.8K Sell
38
-4
-10% -$1.68K 0.01% 190
2023
Q1
$14.4K Buy
42
+3
+8% +$1.01K 0.01% 219
2022
Q4
$14.3K Buy
+39
New +$13.8K 0.01% 205

Other funds holding LLY

True Wealth Design's LLY Position: Q2 2026 in Review

True Wealth Design reduced its Eli Lilly (LLY) stake by 8.3% in Q2 2026, selling an estimated $36.8K and leaving 397 shares worth $476K. The position accounts for 0.11% of the portfolio, ranked #42.

True Wealth Design first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 894 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • True Wealth Design held 397 shares of Eli Lilly worth $476K as of Q2 2026.
  • True Wealth Design sold 36 Eli Lilly shares in Q2 2026, an estimated $36.8K.
  • Eli Lilly made up 0.11% of True Wealth Design's portfolio in Q2 2026, its #42 holding.
  • True Wealth Design first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 894 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.